Anti-bacterial
- Active ingredient (INN)
- moxifloxacin
- Composition (active ingredients)
- moxifloxacin hydrochloride - 436,4 mg (in terms of moxifloxacin - 400,0 mg)
- Фармакотерапевтическая группа
- antimicrobial agent - fluoroquinolone
- Pharmacotherapeutic group
- film-coated tablets 400 mg №5
- Сonditions of supply
- on prescription
Indications
Indications
Infectious and inflammatory diseases caused by microorganisms sensitive to moxifloxacin:- acute sinusitis;
- exacerbation of chronic bronchitis;
- uncomplicated infections of the skin and subcutaneous structures;
- community-acquired pneumonia, including community-acquired pneumonia, the causative agents of which are strains of microorganisms with multiple antibiotic resistance;
- complicated infections of the skin and subcutaneous structures (including infected diabetic foot);
- complicated intra-abdominal infections, including polymicrobial infections, including intraperitoneal abscesses;
- uncomplicated inflammatory diseases of the pelvic organs (including salpingitis and endometritis).
Dosage regimen
Dosage regimen
Recommended dosage regimen of moxifloxacin: 400 mg (1 tablet) 1 time per day. The duration of treatment is determined by the location and severity of the infection, as well as the clinical effect.
- Exacerbation of chronic bronchitis in adults
-
course of treatment 5 to 10 days
- Acute sinusitis in adults
-
course of treatment 7 days
- Uncomplicated infections of the skin and subcutaneous structures in adults
-
total duration of step therapy is 7-14 days
- Community-acquired pneumonia in adults
-
the total duration of step therapy is 7 to 21 days
- Complicated infections of the skin and subcutaneous structures in adults
-
the total duration of step therapy is 5-14 days
- Complicated Intraabdominal Infections in adults
-
course of treatment 14 days
- Uncomplicated inflammatory diseases of the pelvic organs in adults
Contraindications
There are contraindications, consult with a specialist before use
